In mechanism, LOXL1-AS1, as ceRNA, affects the biological phenotype of tumor cells by activating miRNAs and regulating target genes and related signal pathways (such as PI3K/AKT signal pathway and MAPK signal pathway). The gene discussed is AKT1; the disease is neoplasm.